Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 71

1.

Hydrogen Peroxide Mediates Artemisinin-Derived C-16 Carba-Dimer-Induced Toxicity of Human Cancer Cells.

Kalen AL, Wagner BA, Sarsour EH, Kumar MG, Reedy JL, Buettner GR, Barua NC, Goswami PC.

Antioxidants (Basel). 2020 Jan 26;9(2). pii: E108. doi: 10.3390/antiox9020108.

2.

Systematic review of human gut resistome studies revealed variable definitions and approaches.

Ho J, Yeoh YK, Barua N, Chen Z, Lui G, Wong SH, Yang X, Chan MC, Chan PK, Hawkey PM, Ip M.

Gut Microbes. 2020 Jan 16:1-12. doi: 10.1080/19490976.2019.1700755. [Epub ahead of print]

PMID:
31942825
3.

Deep brain stimulation: practical insights and common queries.

Baig F, Robb T, Mooney L, Robbins C, Norris C, Barua N, Szewczyk-Krolikowski K, Whone A.

Pract Neurol. 2019 Dec;19(6):502-507. doi: 10.1136/practneurol-2019-002275. Epub 2019 Jul 29.

PMID:
31358573
4.

Design, synthesis and biological evaluation of antimicrobial diarylimine and -amine compounds targeting the interaction between the bacterial NusB and NusE proteins.

Qiu Y, Chan ST, Lin L, Shek TL, Tsang TF, Barua N, Zhang Y, Ip M, Chan PK, Blanchard N, Hanquet G, Zuo Z, Yang X, Ma C.

Eur J Med Chem. 2019 Sep 15;178:214-231. doi: 10.1016/j.ejmech.2019.05.090. Epub 2019 Jun 3.

PMID:
31185412
5.

Identification of Critical Surface Parameters Driving Lectin-Mediated Capture of Bacteria from Solution.

Masigol M, Fattahi N, Barua N, Lokitz BS, Retterer ST, Platt TG, Hansen RR.

Biomacromolecules. 2019 Jul 8;20(7):2852-2863. doi: 10.1021/acs.biomac.9b00609. Epub 2019 Jun 17.

PMID:
31150217
6.

Efficient and unique cobarcoding of second-generation sequencing reads from long DNA molecules enabling cost-effective and accurate sequencing, haplotyping, and de novo assembly.

Wang O, Chin R, Cheng X, Wu MKY, Mao Q, Tang J, Sun Y, Anderson E, Lam HK, Chen D, Zhou Y, Wang L, Fan F, Zou Y, Xie Y, Zhang RY, Drmanac S, Nguyen D, Xu C, Villarosa C, Gablenz S, Barua N, Nguyen S, Tian W, Liu JS, Wang J, Liu X, Qi X, Chen A, Wang H, Dong Y, Zhang W, Alexeev A, Yang H, Wang J, Kristiansen K, Xu X, Drmanac R, Peters BA.

Genome Res. 2019 May;29(5):798-808. doi: 10.1101/gr.245126.118. Epub 2019 Apr 2.

7.

Extended Treatment with Glial Cell Line-Derived Neurotrophic Factor in Parkinson's Disease.

Whone AL, Boca M, Luz M, Woolley M, Mooney L, Dharia S, Broadfoot J, Cronin D, Schroers C, Barua NU, Longpre L, Barclay CL, Boiko C, Johnson GA, Fibiger HC, Harrison R, Lewis O, Pritchard G, Howell M, Irving C, Johnson D, Kinch S, Marshall C, Lawrence AD, Blinder S, Sossi V, Stoessl AJ, Skinner P, Mohr E, Gill SS.

J Parkinsons Dis. 2019;9(2):301-313. doi: 10.3233/JPD-191576.

8.

Randomized trial of intermittent intraputamenal glial cell line-derived neurotrophic factor in Parkinson's disease.

Whone A, Luz M, Boca M, Woolley M, Mooney L, Dharia S, Broadfoot J, Cronin D, Schroers C, Barua NU, Longpre L, Barclay CL, Boiko C, Johnson GA, Fibiger HC, Harrison R, Lewis O, Pritchard G, Howell M, Irving C, Johnson D, Kinch S, Marshall C, Lawrence AD, Blinder S, Sossi V, Stoessl AJ, Skinner P, Mohr E, Gill SS.

Brain. 2019 Mar 1;142(3):512-525. doi: 10.1093/brain/awz023.

9.

Combined use of CDK4/6 and mTOR inhibitors induce synergistic growth arrest of diffuse intrinsic pontine glioma cells via mutual downregulation of mTORC1 activity.

Asby DJ, Killick-Cole CL, Boulter LJ, Singleton WG, Asby CA, Wyatt MJ, Barua NU, Bienemann AS, Gill SS.

Cancer Manag Res. 2018 Sep 12;10:3483-3500. doi: 10.2147/CMAR.S167095. eCollection 2018.

10.

Maximising coverage of brain structures using controlled reflux, convection-enhanced delivery and the recessed step catheter.

Lewis O, Woolley M, Johnson DE, Fletcher J, Fenech J, Pietrzyk MW, Barua NU, Bienemann AS, Singleton W, Evans SL, Gill SS.

J Neurosci Methods. 2018 Oct 1;308:337-345. doi: 10.1016/j.jneumeth.2018.08.029. Epub 2018 Sep 1.

PMID:
30179705
11.

Fabricating Reactive Surfaces with Brush-like and Crosslinked Films of Azlactone-Functionalized Block Co-Polymers.

Masigol M, Barua N, Lokitz BS, Hansen RR.

J Vis Exp. 2018 Jun 30;(136). doi: 10.3791/57562.

PMID:
30010667
12.

Clinical and genetic analysis of a rare syndrome associated with neoteny.

Walker RF, Ciotlos S, Mao Q, Chin R, Drmanac S, Barua N, Agarwal MR, Zhang RY, Li Z, Wu MKY, Sun K, Lee K, Nguyen S, Liu JS, Carnevali P, Drmanac R, Peters BA.

Genet Med. 2018 Apr;20(5):495-502. doi: 10.1038/gim.2017.140. Epub 2017 Sep 21.

PMID:
29758565
13.

Drug Delivery for Movement Disorders.

Barua N, Gill S.

Prog Neurol Surg. 2018;33:243-252. doi: 10.1159/000481108. Epub 2018 Jan 12. Review.

PMID:
29332088
14.

Repurposing the anti-epileptic drug sodium valproate as an adjuvant treatment for diffuse intrinsic pontine glioma.

Killick-Cole CL, Singleton WGB, Bienemann AS, Asby DJ, Wyatt MJ, Boulter LJ, Barua NU, Gill SS.

PLoS One. 2017 May 25;12(5):e0176855. doi: 10.1371/journal.pone.0176855. eCollection 2017.

15.

Convection enhanced delivery of panobinostat (LBH589)-loaded pluronic nano-micelles prolongs survival in the F98 rat glioma model.

Singleton WG, Collins AM, Bienemann AS, Killick-Cole CL, Haynes HR, Asby DJ, Butts CP, Wyatt MJ, Barua NU, Gill SS.

Int J Nanomedicine. 2017 Feb 21;12:1385-1399. doi: 10.2147/IJN.S125300. eCollection 2017.

16.

Single Electrode Deep Brain Stimulation with Dual Targeting at Dual Frequency for the Treatment of Chronic Pain: A Case Series and Review of the Literature.

Hollingworth M, Sims-Williams HP, Pickering AE, Barua N, Patel NK.

Brain Sci. 2017 Jan 13;7(1). pii: E9. doi: 10.3390/brainsci7010009. Review.

17.

Acetylcholinesterase inhibitory activity of stigmasterol & hexacosanol is responsible for larvicidal and repellent properties of Chromolaena odorata.

Gade S, Rajamanikyam M, Vadlapudi V, Nukala KM, Aluvala R, Giddigari C, Karanam NJ, Barua NC, Pandey R, Upadhyayula VSV, Sripadi P, Amanchy R, Upadhyayula SM.

Biochim Biophys Acta Gen Subj. 2017 Mar;1861(3):541-550. doi: 10.1016/j.bbagen.2016.11.044. Epub 2016 Dec 1.

PMID:
27916676
18.

The whole genome sequences and experimentally phased haplotypes of over 100 personal genomes.

Mao Q, Ciotlos S, Zhang RY, Ball MP, Chin R, Carnevali P, Barua N, Nguyen S, Agarwal MR, Clegg T, Connelly A, Vandewege W, Zaranek AW, Estep PW, Church GM, Drmanac R, Peters BA.

Gigascience. 2016 Oct 11;5(1):42.

20.

Chronic, intermittent convection-enhanced delivery devices.

Lewis O, Woolley M, Johnson D, Rosser A, Barua NU, Bienemann AS, Gill SS, Evans S.

J Neurosci Methods. 2016 Feb 1;259:47-56. doi: 10.1016/j.jneumeth.2015.11.008. Epub 2015 Nov 23. Review.

21.

Convection-enhanced delivery of MANF--volume of distribution analysis in porcine putamen and substantia nigra.

Barua NU, Bienemann AS, Woolley M, Wyatt MJ, Johnson D, Lewis O, Irving C, Pritchard G, Gill S.

J Neurol Sci. 2015 Oct 15;357(1-2):264-9. doi: 10.1016/j.jns.2015.08.003. Epub 2015 Aug 6.

PMID:
26276514
22.

Convection-Enhanced Delivery of Carboplatin PLGA Nanoparticles for the Treatment of Glioblastoma.

Arshad A, Yang B, Bienemann AS, Barua NU, Wyatt MJ, Woolley M, Johnson DE, Edler KJ, Gill SS.

PLoS One. 2015 Jul 17;10(7):e0132266. doi: 10.1371/journal.pone.0132266. eCollection 2015.

23.

Synthesis of a novel series of fluoroarene derivatives of artemisinin as potent antifungal and anticancer agent.

Buragohain P, Surineni N, Barua NC, Bhuyan PD, Boruah P, Borah JC, Laisharm S, Moirangthem DS.

Bioorg Med Chem Lett. 2015 Aug 15;25(16):3338-41. doi: 10.1016/j.bmcl.2015.05.067. Epub 2015 May 30.

PMID:
26099535
24.

Stereoselective chlorothiolation of artemisinin-derived C-10 oxa terminal alkynes.

Surineni N, Buragohain P, Barua NC.

Mol Divers. 2015 Nov;19(4):717-24. doi: 10.1007/s11030-015-9607-1. Epub 2015 Jun 19.

PMID:
26084957
25.

A carbazole alkaloid deactivates mTOR through the suppression of rictor and that induces apoptosis in lung cancer cells.

Chatterjee P, Seal S, Mukherjee S, Kundu R, Bhuyan M, Barua NC, Baruah PK, Babu SP, Bhattacharya S.

Mol Cell Biochem. 2015 Jul;405(1-2):149-58. doi: 10.1007/s11010-015-2406-2. Epub 2015 Apr 17.

PMID:
25893736
26.

Convection-enhanced drug delivery: prospects for glioblastoma treatment.

Barua NU, Gill SS.

CNS Oncol. 2014;3(5):313-6. doi: 10.2217/cns.14.41. No abstract available.

27.

A novel implantable catheter system with transcutaneous port for intermittent convection-enhanced delivery of carboplatin for recurrent glioblastoma.

Barua NU, Hopkins K, Woolley M, O'Sullivan S, Harrison R, Edwards RJ, Bienemann AS, Wyatt MJ, Arshad A, Gill SS.

Drug Deliv. 2016;23(1):167-73. doi: 10.3109/10717544.2014.908248. Epub 2014 May 2.

PMID:
24786643
28.

Treatment seeking and health financing in selected poor urban neighbourhoods in India, Indonesia and Thailand.

Seeberg J, Pannarunothai S, Padmawati RS, Trisnantoro L, Barua N, Pandav CS.

Soc Sci Med. 2014 Feb;102:49-57. doi: 10.1016/j.socscimed.2013.11.039. Epub 2013 Dec 3.

PMID:
24565141
29.

Preclinical evaluation of an O(6)-methylguanine-DNA methyltransferase-siRNA/liposome complex administered by convection-enhanced delivery to rat and porcine brains.

Tsujiuchi T, Natsume A, Motomura K, Kondo G, Ranjit M, Hachisu R, Sugimura I, Tomita S, Takehara I, Woolley M, Barua NU, Gill SS, Bienemann AS, Yamashita Y, Toyokuni S, Wakabayashi T.

Am J Transl Res. 2014 Jan 15;6(2):169-78. eCollection 2014.

30.

Synthesis of a novel series of artemisinin dimers with potent anticancer activity involving Sonogashira cross-coupling reaction.

Buragohain P, Saikia B, Surineni N, Barua NC, Saxena AK, Suri N.

Bioorg Med Chem Lett. 2014 Jan 1;24(1):237-9. doi: 10.1016/j.bmcl.2013.11.032. Epub 2013 Nov 23.

PMID:
24332623
31.

A naturally derived small molecule disrupts ligand-dependent and ligand-independent androgen receptor signaling in human prostate cancer cells.

Amin KS, Jagadeesh S, Baishya G, Rao PG, Barua NC, Bhattacharya S, Banerjee PP.

Mol Cancer Ther. 2014 Feb;13(2):341-52. doi: 10.1158/1535-7163.MCT-13-0478. Epub 2013 Nov 20.

32.

Mahanine restores RASSF1A expression by down-regulating DNMT1 and DNMT3B in prostate cancer cells.

Agarwal S, Amin KS, Jagadeesh S, Baishay G, Rao PG, Barua NC, Bhattacharya S, Banerjee PP.

Mol Cancer. 2013 Aug 30;12(1):99. doi: 10.1186/1476-4598-12-99.

33.

Convection-enhanced delivery of AAV2 in white matter--a novel method for gene delivery to cerebral cortex.

Barua NU, Woolley M, Bienemann AS, Johnson D, Wyatt MJ, Irving C, Lewis O, Castrique E, Gill SS.

J Neurosci Methods. 2013 Oct 30;220(1):1-8. doi: 10.1016/j.jneumeth.2013.08.011. Epub 2013 Aug 27.

PMID:
23988614
34.

Convection-enhanced drug delivery to the brain: therapeutic potential and neuropathological considerations.

Barua NU, Gill SS, Love S.

Brain Pathol. 2014 Mar;24(2):117-27. doi: 10.1111/bpa.12082. Epub 2013 Sep 11. Review.

PMID:
23944716
35.

In vitro and in vivo testing of a novel recessed-step catheter for reflux-free convection-enhanced drug delivery to the brain.

Gill T, Barua NU, Woolley M, Bienemann AS, Johnson DE, S O'Sullivan, Murray G, Fennelly C, Lewis O, Irving C, Wyatt MJ, Moore P, Gill SS.

J Neurosci Methods. 2013 Sep 30;219(1):1-9. doi: 10.1016/j.jneumeth.2013.06.008. Epub 2013 Jul 5.

PMID:
23835009
36.

Robot-guided convection-enhanced delivery of carboplatin for advanced brainstem glioma.

Barua NU, Lowis SP, Woolley M, O'Sullivan S, Harrison R, Gill SS.

Acta Neurochir (Wien). 2013 Aug;155(8):1459-65. doi: 10.1007/s00701-013-1700-6. Epub 2013 Apr 18.

PMID:
23595829
37.

Clearance and toxicity of recombinant methionyl human glial cell line-derived neurotrophic factor (r-metHu GDNF) following acute convection-enhanced delivery into the striatum.

Taylor H, Barua N, Bienemann A, Wyatt M, Castrique E, Foster R, Luz M, Fibiger C, Mohr E, Gill S.

PLoS One. 2013;8(3):e56186. doi: 10.1371/journal.pone.0056186. Epub 2013 Mar 20.

38.

Intermittent convection-enhanced delivery to the brain through a novel transcutaneous bone-anchored port.

Barua NU, Woolley M, Bienemann AS, Johnson DE, Lewis O, Wyatt MJ, Irving C, O'Sullivan S, Murray G, Fennelly C, Skinner P, Gill SS.

J Neurosci Methods. 2013 Apr 15;214(2):223-32. doi: 10.1016/j.jneumeth.2013.02.007. Epub 2013 Feb 16.

PMID:
23419699
39.

GDNF, NGF and BDNF as therapeutic options for neurodegeneration.

Allen SJ, Watson JJ, Shoemark DK, Barua NU, Patel NK.

Pharmacol Ther. 2013 May;138(2):155-75. doi: 10.1016/j.pharmthera.2013.01.004. Epub 2013 Jan 21. Review.

PMID:
23348013
40.

Rapid microwave assisted synthesis and antimicrobial bioevaluation of novel steroidal chalcones.

Kakati D, Sarma RK, Saikia R, Barua NC, Sarma JC.

Steroids. 2013 Mar;78(3):321-6. doi: 10.1016/j.steroids.2012.12.003. Epub 2012 Dec 31.

PMID:
23287649
41.

First total synthesis of Debilisone C.

Saikia B, Devi TJ, Barua NC.

Org Biomol Chem. 2013 Feb 14;11(6):905-13. doi: 10.1039/c2ob26329g. Epub 2012 Dec 18.

PMID:
23250232
42.

Vapor of volatile oils from Litsea cubeba seed induces apoptosis and causes cell cycle arrest in lung cancer cells.

Seal S, Chatterjee P, Bhattacharya S, Pal D, Dasgupta S, Kundu R, Mukherjee S, Bhattacharya S, Bhuyan M, Bhattacharyya PR, Baishya G, Barua NC, Baruah PK, Rao PG, Bhattacharya S.

PLoS One. 2012;7(10):e47014. doi: 10.1371/journal.pone.0047014. Epub 2012 Oct 16.

43.

Anaesthetic complications in pigs undergoing MRI guided convection enhanced drug delivery to the brain: a case series.

Jones A, Bienemann A, Barua N, Murison PJ, Gill S.

Vet Anaesth Analg. 2012 Nov;39(6):647-52. doi: 10.1111/j.1467-2995.2012.00767.x. Epub 2012 Aug 11.

PMID:
22882604
44.

Convection-enhanced delivery of neprilysin: a novel amyloid-β-degrading therapeutic strategy.

Barua NU, Miners JS, Bienemann AS, Wyatt MJ, Welser K, Tabor AB, Hailes HC, Love S, Gill SS.

J Alzheimers Dis. 2012;32(1):43-56.

PMID:
22751177
45.

A rare case of ocular onchocerciasis in India.

Barua P, Sharma A, Hazarika NK, Barua N, Bhuyan S, Alam ST.

Southeast Asian J Trop Med Public Health. 2011 Nov;42(6):1359-64.

PMID:
22299403
46.

Intrastriatal convection-enhanced delivery results in widespread perivascular distribution in a pre-clinical model.

Barua NU, Bienemann AS, Hesketh S, Wyatt MJ, Castrique E, Love S, Gill SS.

Fluids Barriers CNS. 2012 Jan 20;9(1):2. doi: 10.1186/2045-8118-9-2.

47.

DFT-based QSAR models to predict the antimycobacterial activity of chalcones.

Barua N, Sarmah P, Hussain I, Deka RC, Buragohain AK.

Chem Biol Drug Des. 2012 Apr;79(4):553-9. doi: 10.1111/j.1747-0285.2011.01289.x. Epub 2012 Jan 30.

PMID:
22151277
48.

The development of an implantable catheter system for chronic or intermittent convection-enhanced delivery.

Bienemann A, White E, Woolley M, Castrique E, Johnson DE, Wyatt M, Murray G, Taylor H, Barua N, Gill SS.

J Neurosci Methods. 2012 Jan 30;203(2):284-91. doi: 10.1016/j.jneumeth.2011.10.002. Epub 2011 Oct 12.

PMID:
22015599
49.

Aβ-degrading enzymes: potential for treatment of Alzheimer disease.

Miners JS, Barua N, Kehoe PG, Gill S, Love S.

J Neuropathol Exp Neurol. 2011 Nov;70(11):944-59. doi: 10.1097/NEN.0b013e3182345e46. Review.

PMID:
22002425
50.

The allure of the private practitioner: is this the only alternative for the urban poor in India?

Barua N, Pandav CS.

Indian J Public Health. 2011 Apr-Jun;55(2):107-14. doi: 10.4103/0019-557X.85242.

Supplemental Content

Support Center